0B common stock + 0B senior notes offering Mon Nov 2 2026 — preliminary prospectus supplements filed; last reported ORCL sale 30.67 on Oct 30; use of proceeds general corporate inc. capex and debt repayment; BofA Securities sole book-running representative for equity; shares outstanding 3.024B pre-raise → 3.100B assuming full issuance at ref price (~2.5% dilution); mandatory 60-day equity lock-up on further common-stock issuance; closings not conditioned on each other; stock -8.76% during Mon Nov 2 regular session as AI-capex funding footprint widens" /> 0B common stock + 0B senior notes offering Mon Nov 2 2026 — preliminary prospectus supplements filed; last reported ORCL sale 30.67 on Oct 30; use of proceeds general corporate inc. capex and debt repayment; BofA Securities sole book-running representative for equity; shares outstanding 3.024B pre-raise → 3.100B assuming full issuance at ref price (~2.5% dilution); mandatory 60-day equity lock-up on further common-stock issuance; closings not conditioned on each other; stock -8.76% during Mon Nov 2 regular session as AI-capex funding footprint widens" />